Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues
PNMD
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Psychoneuromentalism Disorder is a disorder arising in the mind; that is related to the mental and emotional state of a person. It is the science of mental life. The body has a natural design to heal itself. This is a mental phenomena that cannot be explained, until now. Psychoneuromentalism Disorder is a new condition resulting from behavioral impairments, neurodiversity, and neurobehavioral dysfunctions that are related to the mental and emotional state of a participant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Oct 2024
Shorter than P25 for early_phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2021
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedStudy Start
First participant enrolled
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2025
CompletedAugust 12, 2024
August 1, 2024
9 months
December 13, 2021
August 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Outcomes for those diagnosed with Psychoneuromentalism Disorder
Memory will become more clear.
4-6 weeks
Secondary Outcomes (1)
Primary Outcomes for those diagnosed with Psychoneuromentalism Disorder
8-12 weeks
Other Outcomes (2)
Primary Outcomes for those diagnosed with Psychoneuromentalism Disorder
2-3 weeks
Primary Outcomes for those diagnosed with Psychoneuromentalism Disorder
6-8 weeks
Study Arms (1)
Intervention Techniques for Psychoneuromentalism Disorder
EXPERIMENTALThe Interventions to be administered will be as follows: 1. Ashwagandha Herb Tincture and Supplement 2. Damiana Herb Tincture 3. Passion Flower Herb Tincture 4. Grapeseed Extract- Capsule 5. Rhodiola- Herb Tincture 6. Sea Moss Supplement Capsule 7. Theocentric Psychological Counseling 8. Clinical Yoga 9. Meditation 10. Mental Imagery 11. Decompartmentalization Framework 12. Dietary Supplements 13. Applied Relaxation (Music Meditation, Breathing Techniques) 14. Pain Relaxation Techniques 15. Meridian Acupuncture
Interventions
I will also be using mental imagery, consciousness, cognition, and cognitive psychology during this study to show the effectiveness of the conscious mind, and how the mind can influence behavior. Decompartmentalize means to remove excessive compartmentalization; to restore from a compartmentalized state; to merge back together.
I will make and administer liquid herbal tinctures that will be made from all natural leafs, roots and flowers. I will focus on and track the participants' diagnosis, side effects, and how they feel before, during and after taking the liquid tincture.
I will have the participants focus on a particular shape, sound or image that they can see, think, or hear. This will allow the participant to have a clear mind, and release any negative thoughts, negative energy and boost their moods and their 5 senses.
I will show the participants many different yoga positions that will give them a peace of mind, stretch their muscles and release any tension throughout their body, and have an overall well-being, as well as promoting mindfulness.
I will have the participants take an herbal supplement and/or vitamin that relates to the symptoms and current issues/diagnosis they have. The Dietary Supplements/Vitamins will enhance their capacity to overcome their health conditions, protect their body from unwanted germs and bacteria, and relieve the participants' mind and body from the symptoms they are experiencing based on their current condition.
Applied Relaxation is a specialized form of relaxation training that aims to teach the participant how to relax in common social situations. Mindfulness training encourages participants to gain psychological distance from their worries and negative emotions, seeing them as an observer would see them. 2 types of mindfulness will be used, which is mindfulness-based stress reduction and mindfulness-based cognitive therapy. Treatment starts with general education about stress and social anxiety.
Relaxation can reduce the feelings of stress, helping them to gain more control. Reduce pain by decreasing muscle tension, aches and pains. The body releases endorphins (the body's natural pain-killers) to relieve pain. Yoga incorporates breath control, meditation, and gentle movements to stretch and strengthen muscles. Mind-body techniques, which includes meditation, mindfulness, and breathing exercises help you restore a sense of control over your body and turn down the "fight or flight" response, which can worsen chronic muscle tension and pain.
To enhance the lives of add to the lives of those who are well adjusted but know they have a greater potential within themselves to ring forth and live more fulfilling lives,
Eligibility Criteria
You may qualify if:
- Clinical Diagnosis of anxiety, schizoaffective disorder, bipolar disorder, ADHD, Dementia, or other psychological issues and disorders; autoimmune disease such as fibromyalgia, lupus, and thyroid disease, neuropathy and chronic fatigue syndrome
- Must be able to swallow tablets
You may not qualify if:
- Children under the age of 18
- Must not be on any blood thinner medications
- Chronically ill patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Faith A Richardson, BSW, MPA, PhD
Restored Purpose Counseling Alliance
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Recent studies suggest that neurotrophic factors play an important role in the pathogenesis of depression as well as the therapies for depression.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2021
First Posted
January 31, 2024
Study Start
October 10, 2024
Primary Completion
June 29, 2025
Study Completion
September 19, 2025
Last Updated
August 12, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- The data will become available on January 7, 2023.
- Access Criteria
- Please send me an email if you would like to have access to my research and reports.
At this time, I don't have a specific plan set in place. I will take the necessary steps to make the IPD available to other researchers once I come up with a description.